- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06706674
Multicenterstudie av Lumateperon för behandling av irritabilitet associerad med autismspektrumstörning (ASD) hos pediatriska patienter
En randomiserad, dubbelblind, placebokontrollerad, multicenterstudie för att bedöma effektiviteten och säkerheten av Lumateperone vid behandling av irritabilitet associerad med autismspektrumstörning hos pediatriska patienter i åldern 5 till 17 år
This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) and confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL).
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
The study will be conducted in 3 phases:
- Screening Period (up to 14 days) during which patient eligibility will be assessed.
- Double-blind Treatment Period (DBTP) (6 weeks) during which all patients will be randomized in a 1:1:1 ratio to receive either lumateperone high dose, lumateperone low dose, or placebo as a once daily dose.
- Safety Follow-up Period (1 week) during which all patients will return to the clinic for a safety follow-up (SFU) visit approximately 1 week after the last dose of study drug.
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 3
Kontakter och platser
Studiekontakt
- Namn: Study Contact
- Telefonnummer: 844-434-4210
- E-post: Participate-In-This-Study1@its.jnj.com
Studieorter
-
-
Arkansas
-
Little Rock, Arkansas, Förenta staterna, 72204
- Rekrytering
- Pillar Clinical Research, LLC
-
-
California
-
Sacramento, California, Förenta staterna, 95817
- Rekrytering
- University Of California - Davis
-
Sherman Oaks, California, Förenta staterna, 91403
- Rekrytering
- California Neuroscience Research
-
-
Connecticut
-
New Haven, Connecticut, Förenta staterna, 06519
- Rekrytering
- Yale University School Of Medicine
-
-
Florida
-
Hialeah, Florida, Förenta staterna, 33012
- Rekrytering
- United Research Institute
-
Homestead, Florida, Förenta staterna, 33033
- Upphängd
- Advanced Research Institute of Miami
-
Miami, Florida, Förenta staterna, 33165
- Rekrytering
- AP Medical Research
-
Miami, Florida, Förenta staterna, 33122
- Upphängd
- Vital Care Research
-
Miami, Florida, Förenta staterna, 33130
- Rekrytering
- Care Research Center Inc
-
Miami, Florida, Förenta staterna, 33144
- Rekrytering
- Blue Medical Research
-
Miami, Florida, Förenta staterna, 33173
- Avslutad
- GTL Medical and Research Group
-
Miami Gardens, Florida, Förenta staterna, 33056
- Rekrytering
- New Med Research Inc
-
Miami Lakes, Florida, Förenta staterna, 33014
- Upphängd
- Riveldi Biomedical Research
-
Orlando, Florida, Förenta staterna, 32803
- Rekrytering
- APG Research LLC
-
Orlando, Florida, Förenta staterna, 32809
- Avslutad
- Orlando Psychiatric Associates
-
Pompano Beach, Florida, Förenta staterna, 33060
- Rekrytering
- Clinical Research Center of Florida
-
St. Petersburg, Florida, Förenta staterna, 33701
- Rekrytering
- University of South Florida Rothman Center of Neuropsychiatry
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30318
- Avslutad
- Advanced Discovery Research
-
Lawrenceville, Georgia, Förenta staterna, 30046
- Avslutad
- Salveo Integrative Health Inc
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60622
- Rekrytering
- EmVenio Research at Chicago
-
Naperville, Illinois, Förenta staterna, 60563
- Rekrytering
- Baber Research Group
-
-
Indiana
-
Indianapolis, Indiana, Förenta staterna, 46202
- Avslutad
- Riley Hospital for Children at Indiana University Health
-
-
Louisiana
-
Shreveport, Louisiana, Förenta staterna, 71101
- Rekrytering
- Louisiana State University Health Sciences Center Shreveport
-
-
Michigan
-
Bloomfield Hills, Michigan, Förenta staterna, 48302
- Rekrytering
- Neurobehavioral Medicine Group
-
-
Nebraska
-
Lincoln, Nebraska, Förenta staterna, 68526
- Rekrytering
- Alivation Research LLC
-
-
New York
-
New York, New York, Förenta staterna, 10016
- Upphängd
- NYU Child Study Center
-
Orangeburg, New York, Förenta staterna, 10962
- Rekrytering
- Nathan Kline Institute
-
Staten Island, New York, Förenta staterna, 10314
- Rekrytering
- Richmond Behavioral Associates
-
The Bronx, New York, Förenta staterna, 10467
- Rekrytering
- Advantage Clinical Trials
-
The Bronx, New York, Förenta staterna, 10461
- Rekrytering
- Albert Einstein College Of Medicine
-
-
Ohio
-
Avon Lake, Ohio, Förenta staterna, 44012
- Avslutad
- Quest Therapeutics of Avon Lake
-
-
Oklahoma
-
Norman, Oklahoma, Förenta staterna, 73071
- Rekrytering
- Sooner Clinical Research
-
Oklahoma City, Oklahoma, Förenta staterna, 73112
- Rekrytering
- SP Research, PLLC (dba Rivus Wellness & Research Institute)
-
-
South Carolina
-
Charleston, South Carolina, Förenta staterna, 29425
- Rekrytering
- Medical University of South Carolina
-
-
Texas
-
Austin, Texas, Förenta staterna, 78759
- Avslutad
- BioBehavioral Research of Austin PC
-
Coppell, Texas, Förenta staterna, 75019
- Rekrytering
- Texas Research Group
-
Dallas, Texas, Förenta staterna, 75251
- Avslutad
- Future Search Trials of Dallas
-
Fort Worth, Texas, Förenta staterna, 76104
- Rekrytering
- North Texas Clinical Trials
-
Houston, Texas, Förenta staterna, 77090
- Avslutad
- Red Oak Psychiatry Associates
-
-
Virginia
-
Richmond, Virginia, Förenta staterna, 23220
- Rekrytering
- Virginia Commonwealth University
-
-
Washington
-
Everett, Washington, Förenta staterna, 98201
- Rekrytering
- Core Clinical Research
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
All patients must have a legally authorized representative LAR (eg, parent or legal guardian) who is willing and able to be responsible for the safety and well-being of the patient, provide information about the patient's condition, and accompany the patient to study visits.
-
Able to provide consent as follows:
- The patient's LAR must provide written, informed consent.
- When developmentally appropriate based on Investigator judgment, the patient should provide written assent.
-
Male or female patients 5 to 17 years of age. Currently, only patients aged 13 to 17 years will be eligible for enrollment.
-
Meet Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) primary diagnosis of ASD as confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL);
-
ABC-I subscale score of >18 at Screening and Baseline;
-
CGI-S score > 4 with respect to irritability associated with ASD at Screening and Baseline.
Exclusion Criteria:
-
Has a primary psychiatric diagnosis other than ASD. Exceptions include:
- Attention Deficit Hyperactivity Disorder (ADHD). If a patient is taking medication(s) for ADHD, they must be on a stable treatment regimen of these medication(s) for 30 days prior to screening and the treatment regimen is expected to remain stable throughout the study. This must be confirmed by the Investigator and noted in the source records.
- Mild and moderate intellectual disability based on Investigator judgment and DSM-5 criteria (severe and profound intellectual disability are excluded).
-
History or current diagnosis of Rett syndrome or Fragile X syndrome;
-
In the opinion of the Investigator, the patient has a significant risk for suicidal behavior during their participation in the study or
- At Screening, the patient scores "yes" on Suicidal Ideation Items 3, 4, or 5 of the Columbia-Suicide Severity Rating Scale (CSSRS) within 6 months prior to Screening or, at Baseline, the patient scores "yes" on Suicidal Ideation Items 3, 4, or 5 since the Screening Visit;
- At Screening, the patient has had 1 or more suicidal attempts within the 2 years prior to Screening; or
- The patient is considered to be an imminent danger to themselves or others.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Placebo-jämförare: Placebo
Placebo |
Matching Placebo administered orally once daily |
|
Experimentell: Lumateperone high dose
Lumateperone 42 mg for patients ages 13-17 years old |
Lumateperone administered orally once daily |
|
Experimentell: Lumateperone low dose
Lumateperone 21 mg for patients ages 13-17 years old |
Lumateperone administered orally once daily |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Aberrant Behavior Checklist - Irritability (ABC-I)
Tidsram: Week 6
|
The ABC-I subscale contains 15 items which rate symptoms on a scale ranging from 0 (not at all a problem) to 3 (severe). |
Week 6
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Clinical Global Impression-Severity (CGI-S)
Tidsram: Week 6
|
The CGI-S is a clinician-rated scale to assess a patient's overall mental health. The scale ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients). |
Week 6
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Intra-Cellular Therapies, Inc. Clinical Trial, Intra-Cellular Therapies, Inc.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ITI-007-602
- ITI-007-602 (Annan identifierare: Janssen Research & Development, LLC)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .